Warburton Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2054795 TULSA, OK

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$219,831

-$42,742 QoQ

Shares Held

1,740

-7.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#1,868

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Warburton Capital Management, LLC holds $1,474,189 across 5 Drug Manufacturers - General names. GILD ranks #4 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	472	$566,131
2	JNJ	Johnson & Johnson	1,006	$255,493
3	ABBV	AbbVie Inc.	897	$225,721
4	GILD	Gilead Sciences, Inc. This page	1,740	$219,831
5	MRK	Merck & Co., Inc.	1,611	$207,013

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$219,831	1,740	-7.6%	Shares	Sole	2026-08-03
2026-03-31	$262,573	1,884	+9.2%	Shares	Sole	2026-05-01
2025-12-31	$211,849	1,726	—	Shares	Sole	2026-01-23
No filing history on record for this holder in this stock.